This author has not written his bio yet.
But we are proud to say that Ilona Margolis contributed 28 entries already.
Dallas, Texas. April 18, 2023: Etira is pleased to announce that multiple abstracts related to their licensed products showed encouraging preclinical activity in metastatic breast cancer and ovarian cancer. The data, presented at The American Association for Cancer Research (AACR) annual meeting, demonstrate strong efficacy in multiple preclinical models both in vitro and in […]
Dallas, Texas. April 17, 2023: We are excited to congratulate one of our founders, Dr. Ratna Vadlamudi, Professor and Vice Chair for Research, Division of Reproductive Research, Department of Obstetrics & Gynecology, Long School of Medicine, who received the prestigious 2023 Presidential Distinguished Research Scholar Award. The Presidential Awards ceremony, held April 17 at the […]
Dallas, Texas. December 9, 2022: Etira is pleased to report the abstract related to ERX-41 validating its activity in Triple negative breast cancer was presented at the San Antonio Breast Cancer Symposium (SABCS). The SABCS is one of the world’s largest breast cancer meetings driven by a diversity of thought leadership in breast oncology advancements […]
Dallas, Texas. October 31, 2022. We are pleased to share two news articles from Dallas that describe how our brilliant chemist and founder, Dr. Jung-Mo Ahn discovered ERX-41. In his words, Dr. Ahn describes the discovery of ERX-41 as “It’s almost like two elephants are hugging each other, and you’re throwing a pebble to stop […]
Dallas, Texas. October 10, 2022: etiraRx’s lead drug candidate, ERX-41 has been highlighted in the most recent edition of Oncology Times. In an article entitled “Molecule Targets Vulnerability in Triple-Negative Breast Cancer,” Dibash Kumar Das, PhD, summarizes the findings published in the recent Nature Cancer article “Targeting LIPA independent of its lipase activity is a […]
Dallas Texas, September 23, 2022. We are pleased to announce that Etira has been selected as a 2022 BioNTX rising star. The BioNTX iC³ Life Science Summit is a two-day conference, held on September 22-23, 2022 that serves as a forum where industry leaders come together. Here we discuss strategy, exhibit the broad spectrum of […]
Dallas, Texas. July 7, 2022: On the cover of the July 2022 issue of Nature cancer is an image of the endoplasmic reticulum within a cell. Image courtesy of Dr. Andrew S. Moore, Janelia Research Campus. Cover Design by Allen Beattie. Highlighted on the cover is the manuscript by Xihui Liu et al, and our […]
Dallas Office:
3033 Irving Blvd,
Dallas. TX. 75247
Mailing Address:
3060 Pegasus Park Dr.
Dallas. TX. 75247